The trial, titled Intermittent PARP Inhibitor Regimen in Ovarian Cancer (IPIROC), will evaluate whether an intermittent, twice-weekly dosing strategy of the PARP inhibitor rucaparib can reduce side effects and costs while maintaining clinical efficacy in ovarian cancer patients.
GLOBAL SUPPORT CARE
Beyond Borders, Beyond Expectations
ICMR Funds Pan-India Clinical Trial to Test Cost-Effective Dosing of PARP Inhibitor in Ovarian Cancer
UAE, India, Africa, Europe.
For Appointments: +919997126740
Email: contact@globalsupportcare.com
For Emergency: +447488891811
Global Support Care
Beyond Borders, Beyond Expectations.
India Office: Phase 1 District Center Plot No. 4 B, Club Ave Road, Mayur Vihar Phase 1 Extension Mayur Vihar, New Delhi, Delhi, 110091.
Contact No. : +919997126740
UAE Office: 8th Floor, Empire Heights Tower A, 93 Marasi Drive, Business Bay, Dubai.
Treatments
Worldwide
UAE
India
Africa
Europe
GlobalSupportCare@.All rights reserved